Aldeyra Therapeutics, Inc. Annual Interest Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
  • Aldeyra Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $478K, a 9.4% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $2.03M, a 7.01% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2023 was $2.07M, a 22.3% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2022 was $1.69M, a 2.76% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2021 was $1.74M, a 8.51% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.07M +$377K +22.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $1.69M -$48K -2.76% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $1.74M -$162K -8.51% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.9M +$1.3M +215% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $604K +$457K +311% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $147K +$33.3K +29.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $113K +$7.94K +7.53% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 $106K -$6.8K -6.05% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-30
2015 $112K -$132K -54% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $244K +$84.9K +53.3% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $159K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.